NED
Nancy E. Dempze Portfolio holdings
AUM
$173M
This Quarter Return
+3.74%
1 Year Return
+12.54%
3 Year Return
+67.49%
5 Year Return
+107.15%
10 Year Return
–
AUM
$57.1M
AUM Growth
+$57.1M
(+1.7%)
Cap. Flow
-$78.1K
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
33.62%
Holding
83
New
3
Increased
24
Reduced
21
Closed
5
Top Buys
| 1 |
Fortive
FTV
|
$278K |
| 2 |
Analog Devices
ADI
|
$242K |
| 3 |
Abbott
ABT
|
$225K |
| 4 |
DFS
Discover Financial Services
DFS
|
$201K |
| 5 |
Church & Dwight Co
CHD
|
$194K |
Top Sells
| 1 |
Chevron
CVX
|
$362K |
| 2 |
Perrigo
PRGO
|
$232K |
| 3 |
Johnson Controls International
JCI
|
$135K |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$119K |
| 5 |
Emerson Electric
EMR
|
$66.9K |
Sector Composition
| 1 | Healthcare | 24.35% |
| 2 | Technology | 18.5% |
| 3 | Industrials | 15.11% |
| 4 | Consumer Staples | 10.14% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$428B
| $2.45M | 4.3% |
20,777
+75
| +0.4% | +$8.86K |
|
2
3M
MMM
$82B
| $2.27M | 3.98% |
12,880
-32
| -0.2% | -$5.64K |
|
3
Automatic Data Processing
ADP
$121B
| $2.13M | 3.74% |
24,215
-140
| -0.6% | -$12.3K |
|
4
Mastercard
MA
$533B
| $1.99M | 3.49% |
19,590
+860
| +5% | +$87.5K |
|
5
CVS Health
CVS
$93.9B
| $1.97M | 3.46% |
22,183
+20
| +0.1% | +$1.78K |
|
6
Procter & Gamble
PG
$370B
| $1.78M | 3.12% |
19,825
-325
| -2% | -$29.2K |
|
7
Apple
AAPL
$3.39T
| $1.75M | 3.07% |
15,485
+525
| +4% | +$59.4K |
|
8
AptarGroup
ATR
$9.01B
| $1.56M | 2.73% |
20,155
-380
| -2% | -$29.4K |
|
9
Alphabet (Google) Class A
GOOGL
$2.53T
| $1.51M | 2.64% |
1,875
+131
| +8% | +$105K |
|
10
Chubb
CB
$110B
| $1.47M | 2.58% |
11,711
+722
| +7% | +$90.8K |
|
11
Canadian National Railway
CNI
$60.2B
| $1.38M | 2.41% |
21,072
+60
| +0.3% | +$3.92K |
|
12
RTX Corp
RTX
$211B
| $1.29M | 2.25% |
12,655
+524
| +4% | +$53.2K |
|
13
Unilever
UL
$155B
| $1.26M | 2.2% |
26,531
+530
| +2% | +$25.1K |
|
|
14
Abbott
ABT
$228B
| $1.25M | 2.19% |
29,616
+5,316
| +22% | +$225K |
|
15
Fiserv
FI
$73.9B
| $1.25M | 2.19% |
12,600
-125
| -1% | -$12.4K |
|
16
Novartis
NVS
$244B
| $1.22M | 2.13% |
15,389
+204
| +1% | +$16.1K |
|
17
PepsiCo
PEP
$207B
| $1.21M | 2.12% |
11,115
-600
| -5% | -$65.3K |
|
18
Schlumberger
SLB
$53.5B
| $1.09M | 1.92% |
13,915
-80
| -0.6% | -$6.29K |
|
19
Intel
INTC
$105B
| $1.04M | 1.81% |
27,435
| – | – |
|
20
Danaher
DHR
$145B
| $974K | 1.71% |
12,425
+1,467
| +13% | +$115K |
|
21
Gilead Sciences
GILD
$139B
| $903K | 1.58% |
11,420
+969
| +9% | +$76.6K |
|
22
Xylem
XYL
$34B
| $883K | 1.55% |
16,846
+86
| +0.5% | +$4.51K |
|
23
Oracle
ORCL
$627B
| $814K | 1.43% |
20,711
-125
| -0.6% | -$4.91K |
|
24
Microsoft
MSFT
$3.72T
| $802K | 1.4% |
13,938
-50
| -0.4% | -$2.88K |
|
25
Merck
MRK
$213B
| $752K | 1.32% |
12,058
-25
| -0.2% | -$1.56K |
|